The endemic paraganglioma syndrome type 1: origin, spread, and clinical expression

J Clin Endocrinol Metab. 2012 Apr;97(4):E637-41. doi: 10.1210/jc.2011-2597. Epub 2012 Mar 28.

Abstract

Context: Anecdotal evidence suggests a high incidence in Trentino, Italy, of head and neck paragangliomas (HNPGL), a rare autosomal dominant disease called paraganglioma type 1 syndrome and caused by germ-line mutations of the SDHD gene.

Objective: The aim of this study was to investigate the origin, spread, and clinical expression of the disease in this geographic region.

Design, setting, and participants: Trentino natives with HNPGL were recruited for establishing clinical expression of the disease, presence of a founder effect, and age of common ancestor. A large sample of the local population was recruited for determination of mutation prevalence and spread.

Main outcome measures: SDHD genetic testing was offered to first-degree relatives, and clinical surveillance was offered to at-risk carriers. The hypothesis of a founder effect was explored by haplotype analysis, and time to the most recent common ancestor was estimated by decay of haplotype sharing over time.

Results: A total of 287 of the 540 recruited individuals from 95 kindreds carried the SDHD c.341A>G p.Tyr114Cys mutation. The prevalent phenotype was bilateral or multiple HNPGL, with low prevalence of pheochromocytoma and malignant forms. Penetrance was high. A common ancestor was dated between the 14th and 15th century, with the mutation spreading from the Mocheni Valley, a geographic, cultural and, presumably, a genetic isolate to 1.5% of the region's population.

Conclusions: A combination of particular demographic, geographical, and historical conditions has resulted in the oldest and largest SDHD founder effect so far characterized and has transformed a rare disease into an endemic disease with major public health implications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Amino Acid Substitution
  • Endemic Diseases*
  • Female
  • Founder Effect
  • Head and Neck Neoplasms / epidemiology*
  • Head and Neck Neoplasms / genetics
  • Head and Neck Neoplasms / physiopathology*
  • Humans
  • Italy / epidemiology
  • Male
  • Mutation
  • Paraganglioma / epidemiology*
  • Paraganglioma / genetics
  • Paraganglioma / physiopathology*
  • Penetrance
  • Phenotype
  • Prevalence
  • Succinate Dehydrogenase / genetics*

Substances

  • SDHD protein, human
  • Succinate Dehydrogenase